Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI110572

Insulin Infusion in Conscious Dogs: EFFECTS ON SYSTEMIC AND CORONARY HEMODYNAMICS, REGIONAL BLOOD FLOWS, AND PLASMA CATECHOLAMINES

Chang-Seng Liang, John U. Doherty, Robert Faillace, Kishio Maekawa, Stephanie Arnold, Haralambos Gavras, and William B. Hood Jr.

Department of Medicine, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Pharmacology, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Cardiology, Boston City Hospital, Boston, Massachusetts 02118

Thorndike Memorial Laboratory, Boston City Hospital, Boston, Massachusetts 02118

Find articles by Liang, C. in: PubMed | Google Scholar

Department of Medicine, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Pharmacology, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Cardiology, Boston City Hospital, Boston, Massachusetts 02118

Thorndike Memorial Laboratory, Boston City Hospital, Boston, Massachusetts 02118

Find articles by Doherty, J. in: PubMed | Google Scholar

Department of Medicine, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Pharmacology, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Cardiology, Boston City Hospital, Boston, Massachusetts 02118

Thorndike Memorial Laboratory, Boston City Hospital, Boston, Massachusetts 02118

Find articles by Faillace, R. in: PubMed | Google Scholar

Department of Medicine, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Pharmacology, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Cardiology, Boston City Hospital, Boston, Massachusetts 02118

Thorndike Memorial Laboratory, Boston City Hospital, Boston, Massachusetts 02118

Find articles by Maekawa, K. in: PubMed | Google Scholar

Department of Medicine, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Pharmacology, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Cardiology, Boston City Hospital, Boston, Massachusetts 02118

Thorndike Memorial Laboratory, Boston City Hospital, Boston, Massachusetts 02118

Find articles by Arnold, S. in: PubMed | Google Scholar

Department of Medicine, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Pharmacology, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Cardiology, Boston City Hospital, Boston, Massachusetts 02118

Thorndike Memorial Laboratory, Boston City Hospital, Boston, Massachusetts 02118

Find articles by Gavras, H. in: PubMed | Google Scholar

Department of Medicine, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Pharmacology, and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Department of Cardiology, Boston City Hospital, Boston, Massachusetts 02118

Thorndike Memorial Laboratory, Boston City Hospital, Boston, Massachusetts 02118

Find articles by Hood, W. in: PubMed | Google Scholar

Published June 1, 1982 - More info

Published in Volume 69, Issue 6 on June 1, 1982
J Clin Invest. 1982;69(6):1321–1336. https://doi.org/10.1172/JCI110572.
© 1982 The American Society for Clinical Investigation
Published June 1, 1982 - Version history
View PDF
Abstract

Cardiovascular actions of insulin were studied by intravenous infusions of insulin (4 and 8 mU/kg per min) in normal conscious dogs. This resulted in increases in cardiac output, heart rate, and left ventricular derivative of pressure with respect to time (dP/dt) and dP/dt/P, as blood glucose was reduced. The inotropic and chronotropic effects of insulin were not related to hypoglycemia, as they persisted even when blood glucose was restored to control values or when it was prevented from falling by a simultaneous infusion of glucose. These cardiac effects were accompanied by increases in plasma catecholamines, and were abolished by propranolol pretreatment. Both plasma epinephrine and norepinephrine increased during insulin hypoglycemia, but only norepinephrine increased during insulin infusion when euglycemia was maintained.

Mean arterial blood pressure did not change significantly during insulin hypoglycemia, but rose if euglycemia was maintained, probably due to the selective increase in norepinephrine in the latter condition. A pressor response also occurred in propranolol-pretreated dogs during insulin hypoglycemia, but was abolished when the animals also had been pretreated with phentolamine, indicating that the vasoconstrictor action of insulin was mediated via alpha adrenergic receptors.

Insulin infusion increased left ventricular work and myocardial blood flow in dogs with and without hypoglycemia. Myocardial blood flow, however, did not change significantly during insulin infusion in dogs pretreated with propranolol. As propranolol also diminished the inotropic response, it appears that the increase in myocardial blood flow caused by insulin in the normal dog is causally related to the increased myocardial metabolic demand.

Insulin also produced vasomotor effects on other vascular beds. In skeletal muscle, blood flow was increased under all study conditions, except during insulin hypoglycemia after propranolol-pretreatment when unopposed alpha-mediated vasoconstriction was present. The persistent increase in flow during both alpha and beta adrenergic blockade suggests that insulin has a direct dilator effect on skeletal muscle vasculature. In the adrenal gland, flow was increased except during euglycemia, when no rise in plasma epinephrine was observed, suggesting coupling between adrenal flow and catecholamine release. In the splanchnic bed, flow was decreased during euglycemia, when plasma norepinephrine rose, and during beta adrenergic blockade with propranolol, when unopposed alpha-mediated vasoconstriction also predominated. A similar pattern was found in the kidney, except that renal blood flow also fell after combined alpha and beta adrenergic blockade. The results show that the vasomotor effects on regional flows are mediated both via adrenergic mechanisms, and in the case of skeletal muscle and kidney, via mechanisms unrelated to sympathetic stimulation.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1321
page 1321
icon of scanned page 1322
page 1322
icon of scanned page 1323
page 1323
icon of scanned page 1324
page 1324
icon of scanned page 1325
page 1325
icon of scanned page 1326
page 1326
icon of scanned page 1327
page 1327
icon of scanned page 1328
page 1328
icon of scanned page 1329
page 1329
icon of scanned page 1330
page 1330
icon of scanned page 1331
page 1331
icon of scanned page 1332
page 1332
icon of scanned page 1333
page 1333
icon of scanned page 1334
page 1334
icon of scanned page 1335
page 1335
icon of scanned page 1336
page 1336
Version history
  • Version 1 (June 1, 1982): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts